Concepedia

M. Reck

MR

3

Publications

349

Citations

3

H-Index

2007

Active since

Affiliations

Hôpitaux Universitaires de Strasbourg(Current)

M. Reck is an author at Hôpitaux Universitaires de Strasbourg specializing in radiation oncology, medicine, and oncology.

Top concepts

MedicineOncologyRadiation OncologyLung CancerCancer TherapyCancer ResearchHealthRadiologyImmunologyVaccination

Publications per year

2007–2019

3

Publications

3

Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer

Rafael Rosell, G. Robinet, A. Szczęsna et al. · Annals of Oncology · 2007 · 260 citations · Full text

First-line Therapy, Non-small-cell Lung Cancer, Medicine +9

IMpower133: Updated overall survival (OS) analysis of first-line (1L) atezolizumab (atezo) + carboplatin + etoposide in extensive-stage SCLC (ES-SCLC)

M. Reck, Stephen V. Liu, Aaron S. Mansfield et al. · Annals of Oncology · 2019 · 68 citations · Full text

Overall Survival, Medicine, Pharmacology +7

Messenger RNA vaccination in NSCLC: Findings from a phase I/IIa clinical trial.

Michael Sebastian, Lotta von Boehmer, Alfred Zippelius et al. · Journal of Clinical Oncology · 2011 · 21 citations

First Vaccination, Immunology, Immunoediting +21

Rows per page

1–3 of 3